## Abstract Elevated extracellular D‐glucose increases transforming growth factor β1 (TGF‐β1) release from human umbilical vein endothelium (HUVEC). TGF‐β1, via TGF‐β receptors I (TβRI) and TβRII, activates Smad2 and mitogen‐activated protein kinases p44 and p42 (p42/44^mapk^). We studied whether D
Stimulation by ghrelin of p42/p44 mitogen-activated protein kinase through the GHS-R1a receptor: Role of G-proteins and β-arrestins
✍ Scribed by Jesus P. Camiña; Maria Lodeiro; Olga Ischenko; Ana C. Martini; Felipe F. Casanueva
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 582 KB
- Volume
- 213
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Results presented in this study indicate that in human embryonic kidney 293 cells (HEK 293), the ghrelin receptor growth hormone secretagogue receptor type 1a (GHS‐R1a) activates the extracellular signal‐related kinases 1 and 2 (ERK 1/2) via three pathways. One pathway is mediated by the β‐arrestins 1 and 2, and requires entry of the receptor into a multiprotein complex with the β‐arrestins, Src, Raf‐1, and ERK 1/2. A second pathway is G~q/11~‐dependent and involves a Ca^2+^‐dependent PKC (PKCα/β) and Src. A third pathway is G~i~‐dependent and involves phosphoinositide 3‐kinase (PI3K), PKCε, and Src. Our current study reveals that G~i/o~‐ and G~q/11~‐proteins are crucially involved in the β‐arrestin‐mediated ERK 1/2 activation. These results thus support the view that the β‐arrestins act as both scaffolding proteins and signal transducers in ERK 1/2 activation, as reported for other receptors. The different pathways of ERK 1/2 activation suggest that binding to GHS‐R1a activates ERK 1/2 pools at different locations within the cell, and thus probably with different physiological consequences. J. Cell. Physiol. 213: 187–200, 2007. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Several agents that act through G-protein-coupled receptors and also stimulate phosphoinositide-specific phospholipase C (PI-PLC), including angiotensin II, vasopressin, norepinephrine, and prostaglandin (PG) F 2a , activated the ERK1 (p44 mapk ) and ERK2 (p42 mapk ) members of the mitogen-activated